Clark, Richard H; Kenyon, Julia C; Bartlett, Nathan W.; Tscharke, David; Smith, Geoffrey
Vaccinia virus (VACV) is the vaccine that was used to eradicate smallpox and is being developed as a recombinant vaccine for other pathogens. Removal of genes encoding immunomodulatory proteins expressed by VACV may enhance virus immunogenicity and improve its potential as a vaccine. Protein A41 is a candidate for removal, having sequence similarity to the VACV chemokine-binding protein, vCKBP, and an association with reduced inflammation during dermal infection. Here, it is shown that, at low...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.